IDEAYA Biosciences Eulerpool Nyheter

IDEAYA Biosciences Eulerpool News

IDEAYA Biosciences Aksje Nyheter

IDEAYA Biosciences blir fulgt av mange journalister og investorer over hele verden. De nyeste IDEAYA Biosciences nyhetene presenterer vi her.

• ·

  Yahoo
  IDEAYA Announces Pricing of Public Offering
• ·

  Yahoo
  IDEAYA Biosciences reports positive data from Phase II trial of cancer treatment
• ·

  SeekingAlpha
  Ideaya Biosciences: Poised For Success In Bladder And Lung Cancer?
• ·

  Yahoo
  IDEAYA Announces Positive Interim Phase 2 Monotherapy Expansion Data for IDE397 a Potential First-in-Class MAT2A Inhibitor in MTAP-Deletion Urothelial and Lung Cancer
• ·

  Yahoo
  IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP-Deletion Urothelial and Lung Cancer on Monday, July 8, 2024
• ·

  Yahoo
  IDEAYA Biosciences initiates subject dosing in Phase I bladder cancer trial
• ·

  Yahoo
  IDEAYA Biosciences Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE397 and Trodelvy® Combination in MTAP-Deletion Bladder Cancer
• ·

  Yahoo
  IDEAYA Biosciences Announces Clinical Program Updates for IDE397 a Potential First-in-Class Phase 2 MAT2A Inhibitor Targeting MTAP-Deletion Solid Tumors
• ·

  Market News Video
  IDEAYA Biosciences Breaks Below 200-Day Moving Average - Notable for IDYA
• ·

  Yahoo
  Investors in IDEAYA Biosciences (NASDAQ:IDYA) have seen impressive returns of 277% over the past five years